Müller, Nicole http://orcid.org/0000-0003-4634-0513
Gschwendtner, Kathrin M.
Dwinger, Sarah
Bergelt, Corinna
Eich, Wolfgang
Härter, Martin
Bieber, Christiane
Funding for this research was provided by:
Deutsche Krebshilfe (DKH109956, DKH110010)
Article History
Received: 7 May 2018
Accepted: 6 December 2018
First Online: 7 January 2019
Ethics approval and consent to participate
: The study will be conducted in accordance with the Declaration of Helsinki in its current version (2013). The International Conference of Clinical Harmonization of technical requirements for registration of pharmaceuticals for human use – Good Clinical Practice (ICH-GCP) guidelines are considered.Ethics approval has been obtained from the Ethical Committee of the University Hospital of Heidelberg (approval number: S-453/2015) and the Ethical Committee of the Medical Chamber Hamburg (Ärztekammer Hamburg; approval number: MC-412/15).Study participants will be informed and educated about the purpose of the study before taking part. Physicians can only participate if they give their online (via online questionnaire for inclusion) and written (at T<sub>0</sub>) consent to participate.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.